BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25579756)

  • 41. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment].
    Chelly I; Adouni O; Chouaib S; Azouz H; Nfoussi H; Haouet S; Zitouna M; Kchir N
    Tunis Med; 2011 Dec; 89(12):910-5. PubMed ID: 22198892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
    Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
    Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Our experience in Helicobacter pylori infection and gastric MALToma.
    Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
    Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.
    Kuo SH; Weng WH; Chen ZH; Hsu PN; Wu MS; Lin CW; Jeng HJ; Yeh KH; Tsai HJ; Chen LT; Cheng AL
    Genes Chromosomes Cancer; 2011 Nov; 50(11):908-21. PubMed ID: 21837708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
    Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
    Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy.
    Terai S; Iijima K; Kato K; Dairaku N; Suzuki T; Yoshida M; Koike T; Kitagawa Y; Imatani A; Sekine H; Ohara S; Shimosegawa T
    Tohoku J Exp Med; 2008 Jan; 214(1):79-87. PubMed ID: 18212490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?
    Raderer M; Chott A; Drach J; Montalban C; Dragosics B; Jäger U; Püspök A; Osterreicher C; Zielinski CC
    Ann Oncol; 2002 Jul; 13(7):1094-8. PubMed ID: 12176789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
    Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
    Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
    Kuo SH; Yeh KH; Wu MS; Lin CW; Hsu PN; Wang HP; Chen LT; Cheng AL
    Blood; 2012 May; 119(21):4838-44; quiz 5057. PubMed ID: 22403257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastric diffuse large B-cell lymphoma cured with Helicobacter pylori eradication regardless of whether it contains features of MALT lymphoma.
    Mitsuhashi K; Yamashita K; Goto A; Adachi T; Kondo Y; Kasai K; Suzuki R; Saito M; Arimura Y; Shinomura Y
    Intern Med; 2014; 53(7):695-8. PubMed ID: 24694478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease.
    Raderer M; Osterreicher C; Machold K; Formanek M; Fiebiger W; Penz M; Dragosics B; Chott A
    Ann Oncol; 2001 Jul; 12(7):937-9. PubMed ID: 11521798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?
    Di Raimondo F; Caruso L; Bonanno G; Naso P; Chiarenza A; Fiumara P; Bari A; Palumbo GA; Russo A; Giustolisi R
    Ann Oncol; 2007 Feb; 18(2):351-6. PubMed ID: 17065587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helicobacter pylori-negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysis.
    Gu SX; Siddon AJ; Huntington SF; Jain D
    Am J Clin Pathol; 2023 Dec; 160(6):612-619. PubMed ID: 37556379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.
    Hammel P; Haioun C; Chaumette MT; Gaulard P; Divine M; Reyes F; Delchier JC
    J Clin Oncol; 1995 Oct; 13(10):2524-9. PubMed ID: 7595703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
    Amiot A; Lévy M; Copie-Bergman C; Dupuis J; Szablewski V; Le Baleur Y; Baia M; Belhadj K; Sobhani I; Leroy K; Haioun C; Delchier JC
    Aliment Pharmacol Ther; 2014 Mar; 39(6):619-28. PubMed ID: 24467480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
    Ambrosini V; Rubello D; Castellucci P; Nanni C; Farsad M; Zinzani P; Alavi A; Tehranipour N; Al-Nahhas A; Fanti S
    Nucl Med Rev Cent East Eur; 2006; 9(1):37-40. PubMed ID: 16791802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
    Jäger G; Neumeister P; Brezinschek R; Hinterleitner T; Fiebiger W; Penz M; Neumann HJ; Mlineritsch B; DeSantis M; Quehenberger F; Chott A; Beham-Schmid C; Höfler G; Linkesch W; Raderer M
    J Clin Oncol; 2002 Sep; 20(18):3872-7. PubMed ID: 12228207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric MALT lymphoma - update on diagnosis and treatment.
    Fischbach W
    Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1069-77. PubMed ID: 25439072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.